ArticleFrontiers in digital health2026
Explainable multimodal feature fusion networks for Parkinson's disease prediction.
Article in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multimodal Electrophysiological Signals for Machine Learning-Aided Parkinson's Disease Diagnosis.Biosensors · 2026Article
- Clinically Deployable Handwriting Biomarkers of Parkinson's Disease via Multiscale Attention and Bayesian-Genetic Optimization.Brain and behavior · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by motor and non-motor impairments, where early diagnosis remains challenging due to reliance on subjective clinical assessments. Recent artificial intelligence (AI)-based approaches have demonstrated promise in identifying subtle PD biomarkers from individual modalities such as speech, gait, and handwriting; however, unimodal systems often fail to capture the heterogeneity of the disease and provide limited interpretability. To address these limitations, this study proposes a multimodal deep learning framework that integrates handwriting, gait, and speech modalities using an early feature fusion strategy for robust and interpretable PD detection. Each modality is processed through a dedicated feature extraction pipeline using deep neural networks, followed by static feature concatenation and classification using an XGBoost model. Model transparency is enhanced using explainable AI (XAI) techniques, including SHapley Additive exPlanations (SHAP) and Gradient-weighted Class Activation Mapping (Grad-CAM), enabling clinical interpretability of modality- and feature-level contributions. Experimental evaluation on benchmark datasets demonstrates that the proposed trimodal fusion model achieves an accuracy of 92%, outperforming unimodal handwriting (91%), gait (90%), and speech (74%) models. The fusion framework attains a macro F1-score of 0.89, an area under the ROC curve (AUC) of 0.95, and an average precision (AP) of 0.96, indicating strong discriminative capability and robustness. Confusion matrix analysis reveals balanced sensitivity (90%) and specificity (89%) across classes. Explainability analysis confirms that handwriting tremor patterns, gait force asymmetries, and speech spectral instabilities are key contributors to PD prediction. These results highlight the effectiveness of explainable multimodal AI in delivering accurate, reliable, and clinically interpretable solutions for early PD detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.